The number of adults with diabetes worldwide 1 is expected to increase by 114% from 171 million in 2000 to 366 million in 2030, representing a rise in prevalence from about 2.8% to 4.4%. The ...

Please provide your email address to receive an email when new articles are posted on . RAS blockers had similar mortality benefit by race in patients with HFrEF. RAS blockers improved HF ...

Patients infected by the COVID-19 virus may benefit from treatments that dampen the renin–angiotensin system, according to a review of several animal studies. These preclinical findings generally ...

Figure 3. ACE inhibitors and ARBs have different sites of action within the RAS pathway. The solid arrows indicate activation, and the dashed arrows indicate inhibition. ACE = angiotensin-converting ...